Li, H., Wang, Z., Zhang, J., Wang, Y., Yu, C., Zhang, J., . . . Lv, C. (2018). Feifukang ameliorates pulmonary fibrosis by inhibiting JAK-STAT signaling pathway. BMC Complement Altern Med.
Citação norma ChicagoLi, Hongbo, Zhenkai Wang, Jie Zhang, Youlei Wang, Chen Yu, Jinjin Zhang, Xiaodong Song, and Changjun Lv. "Feifukang Ameliorates Pulmonary Fibrosis By Inhibiting JAK-STAT Signaling Pathway." BMC Complement Altern Med 2018.
MLA citiranjeLi, Hongbo, et al. "Feifukang Ameliorates Pulmonary Fibrosis By Inhibiting JAK-STAT Signaling Pathway." BMC Complement Altern Med 2018.
Opozorilo: Ti citati niso vedno 100% točni.